US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 41.990
  • -0.530-1.25%
Close May 10 16:00 ET
  • 42.000
  • +0.010+0.02%
Post 19:57 ET
5.10BMarket Cap-12241P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apellis Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

172.33M

+284.26%
EPS(YoY)

-0.54

+65.38%
Analyst Rating

Strong Buy

May 8, 2024

Apellis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 217.155M--
--2024/Q2-- / 193.206M--
May 7, 20242024/Q1172.325M / 164.259M--
Feb 27, 20242023/Q4146.377M / 143.592M--
Nov 1, 20232023/Q3110.399M / 99.054M--
Jul 31, 20232023/Q294.969M / 71.120M--
May 4, 20232023/Q144.846M / 26.105M--
--2022/Q422.663M / 24.518M--
Nov 7, 20222022/Q322.056M / 21.591M--
Aug 8, 20222022/Q216.322M / 16.945M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 217.155M--
--2024/Q2-- / 193.206M--
May 7, 20242024/Q1172.325M / 164.259M--
Feb 27, 20242023/Q4146.377M / 143.592M--
Nov 1, 20232023/Q3110.399M / 99.054M--
Jul 31, 20232023/Q294.969M / 71.120M--
May 4, 20232023/Q144.846M / 26.105M--
--2022/Q422.663M / 24.518M--
Nov 7, 20222022/Q322.056M / 21.591M--
Aug 8, 20222022/Q216.322M / 16.945M--

Unlock Free Earnings Estimates

Apellis Pharmaceuticals Earnings Reports

  • Apellis Pharmaceuticals | 10-Q: Quarterly report

    May 7 19:04

  • Apellis Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Mar 1 06:15

  • Apellis Pharmaceuticals | 10-K: Annual report

    Feb 27 20:05

  • Apellis Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 19:02

    • Read more

    Analysis

    Analyst Rating

    Updated: May 8, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Gene Editing
    Gene Editing
    Intraday+1.14%